dr. zhang on the importance of adjuvant clinical trials in rcc
Published 6 years ago • 47 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
1:08
clinical trials in adjuvant rcc
-
1:17
dr. zhang discusses the keynote-564 trial in rcc
-
1:11
dr. zhang on toxicities of treatments in rcc
-
0:53
the role of icis in the adjuvant setting for rcc
-
1:52
dr. zhang on potential of vaccines in rcc
-
4:00
[treatment] dr.jones' analysis on jaseng treatment
-
2:50
small kidney tumor [treating kidney tumours] by dr chong kian tai, asia md
-
9:57
how to select 1st line therapy for metastatic renal cell cancer?
-
1:03
dr. hutson discusses the phase iii atlas study in rcc
-
1:03
dr. zhang on the arches trial in prostate cancer
-
29:37
dr gengwen tian, nkt trial update & new immunotherapy trial opening
-
1:58
dr. plimack on significance of checkmate-025 trial in rcc
-
1:35
dr. george on the use of adjuvant sunitinib in rcc
-
1:44
dr. choueiri on cabosun trial results in rcc
-
2:11
dr. haas on adjuvant sorafenib or sunitinib for rcc
-
2:35
adjuvant therapy in rcc: harnessing prognostic information
-
5:54
adjuvant sunitinib’s role in the treatment of rcc
-
1:32
dr. zhang on challenges with vaccines in renal cell carcinoma
-
3:09
current concepts in adjuvant therapy for rcc from asco gu 2017
-
0:35
the latest developments in adjuvant therapy for rcc
-
1:47
dr. zhang discusses neoadjuvant therapy in kidney cancer
-
0:43
what's on the horizon for adjuvant therapies for rcc?